Characterization of a novel antimycotic agent, cinnamyl benzoate, using yeast-phase Sporothrix schenckii.


Cinnamyl benzoate specifically inhibited the growth of yeast-phase cells of the pathogenic fungus Sporothrix schenckii. A commercially available antimycotic agent, miconazole nitrate, released large amounts of K(+) and Pi from S. schenckii probably due to it damaging the cell membrane, but no such release was observed with cinnamyl benzoate or with another… (More)
DOI: 10.1007/BF00144459


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.